Navigation Links
Orchid gets FDA Approval for Cefotaxime Injections

Orchid Chemicals & Pharmaceuticals, a leading player in the Indian drug industry, has received a formal approval from the US Food and Drug Authority (FDA) for three// of its abbreviated new drug applications (ANDAs) for Cefotaxime.

Orchid will be launching this product in the US through its exclusive distribution partner, Apotex, the Chennai-based company said in a release Wednesday.

The FDA approvals for Cefotaxime ANDAs mark another milestone in Orchid's efforts to offer a full-line injectable product range in the US generic market, it said.

Though a mature off-patent product, Cefotaxime has limited competition and Orchid expects a notable market share and revenue stream from it.

Orchid has filed 31 ANDAs with the FDA and 15 of them have been approved so far.

(Source: IANS)
'"/>




Page: 1

Related medicine news :

1. Orchid Gets USFDA Nod for Cephalexin
2. Orchid to Buy out Bexel Pharma, US
3. Approval for DNA test to detect cystic fibrosis
4. Vaccine For Cervical Cancer Awaits Approval
5. WHO Gives Its Approval For Bird Flu Test Kit
6. FDA Gives Its Approval For Inhaler
7. RotaTeq Gets US Approval
8. Better Communication With FDA Could Speed Up Approval Of New Drugs
9. Nerve Stimulator for Depression Though Not Effective Was Given Approval
10. Ranbaxy Gets USFDA Approval For Doxycycline Tablets
11. Global Education Net Pvt Medical College Gets MCI Approval
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/23/2017)... CA (PRWEB) , ... February 23, 2017 , ... Hamlin ... to announce that they are sponsoring a raffle. Throughout the month of February, patients ... will receive a gift card for a dinner for two at the Cheesecake Factory. ...
(Date:2/23/2017)... ... February 23, 2017 , ... On April 13, 2017, ... “Doping in Sport: How the Culture Might Change,” in conjunction with ... symposium will be held at Pepperdine University in Malibu, California. , Sir Philip ...
(Date:2/23/2017)... PHILADELPHIA (PRWEB) , ... February 23, 2017 , ... ... risk and uncertainty in clinical trials, today announced that Premier Research, a leading ... management solution. , Clinical trials are becoming increasingly complex, due in part to ...
(Date:2/23/2017)... ... February 23, 2017 , ... ... partnership with the Rhode Island Consortium for Autism Research and Treatment (RI-CART) and ... children with autism spectrum disorder (ASD) to see films in an environment that ...
(Date:2/23/2017)... Angeles, CA (PRWEB) , ... February 23, 2017 , ... ... her Smiling Patriot program today with a new Indiegogo campaign . ... care to homeless veterans in the Los Angeles area, either as a participating patient ...
Breaking Medicine News(10 mins):
(Date:2/23/2017)... 23, 2017 LG Innotek today announced that the company ... As its sterilization performance is 1.5 times higher than the competitor,s ... rays in the range of 200 -- 280nm, allowing it to be ... destroying their DNA. LG Innotek,s product emits UV in the range ... Until ...
(Date:2/23/2017)... Research and Markets has announced the addition of the "Global ... 2025" report to their offering. ... The Global Cardiac Prosthetic Devices Market is ... next decade to reach approximately $8.9 billion by 2025. ... the given segments on global as well as regional levels presented ...
(Date:2/23/2017)... February 23, 2017 Tillotts Pharma ... Berlin office was opened in ... . The portfolio includes Entocort ® for the ... treatment of ulcerative colitis, and VistaPrep ® for ... Swiss specialty pharmaceutical company focused on the treatment of ...
Breaking Medicine Technology: